Protagonist Therapeutics (PTGX)
(Delayed Data from NSDQ)
$41.60 USD
-0.08 (-0.19%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $41.61 +0.01 (0.02%) 6:06 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.61 | -7.76% |
Earnings Summary
For their last quarter, Protagonist Therapeutics (PTGX) reported earnings of -$0.50 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for PTGX's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.61 per share, reflecting a year-over-year decrease of 5.17%.
Earnings History
Price & Consensus
Zacks News for PTGX
Protagonist Therapeutics (PTGX) is on the Move, Here's Why the Trend Could be Sustainable
PTGX: What are Zacks experts saying now?
Zacks Private Portfolio Services